Trazodone does not produce the euphoria or rush that people associate with getting high. In controlled studies comparing it to drugs with known abuse potential, participants rated trazodone far lower on measures like “willing to take again,” suggesting it lacks the reinforcing qualities that drive recreational use. What trazodone does produce, reliably and sometimes intensely, is sedation, drowsiness, and dizziness. The gap between “this doesn’t get you high” and “this is completely safe to mess around with” is wide, though, and the drug’s real effects carry risks that are easy to underestimate.
What Trazodone Actually Does to the Brain
Trazodone is an antidepressant, but calling it that undersells how unusual its pharmacology is. Unlike most antidepressants that do one main thing at all doses, trazodone’s effects shift dramatically depending on how much you take. At low doses, in the range of 25 to 100 mg, it primarily blocks serotonin 2A receptors, histamine H1 receptors, and alpha-1 adrenergic receptors. The combined result is heavy sedation with very little antidepressant effect. That’s why low-dose trazodone is one of the most commonly prescribed sleep aids in the country, even though it was never formally approved for insomnia by the FDA.1CNS Spectrums. Mechanism of Action of Trazodone: a Multifunctional Drug
At higher doses, around 150 to 300 mg and above, trazodone starts blocking the serotonin transporter (SERT), which is the mechanism behind its antidepressant action. This is the dose range where it was originally intended to be used. But because the sedation hits hard and early while the antidepressant benefits only kick in at higher doses, many people never reach a therapeutic antidepressant dose. They either can’t tolerate the drowsiness or their prescriber is specifically using that drowsiness as the point.2PubMed Central. Estimation of brain receptor occupancy for trazodone immediate release and once a day formulations
None of these receptor actions produce euphoria. There’s no dopamine surge, no opioid-receptor activation, no GABA-mediated disinhibition of the kind you’d get from benzodiazepines or alcohol. The subjective experience of taking trazodone, even at higher doses, is closer to feeling heavily drowsy and a bit foggy than to feeling pleasurably altered.
How It Compares to Drugs People Actually Abuse
Researchers have directly tested whether trazodone has abuse potential using the standard method: give it to people with histories of sedative abuse alongside known drugs of abuse and ask them which ones they’d want to take again. In one such study, trazodone was compared head-to-head with triazolam, a benzodiazepine. Participants consistently rated trazodone lower on measures thought to predict abuse, including the “willing to take again” scale. The researchers concluded that trazodone has less abuse potential than triazolam and could be a viable alternative for people with histories of substance use problems.3PubMed. Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans
This finding is part of why trazodone is not a controlled substance. Unlike benzodiazepines, Z-drugs like zolpidem, and other common sleep medications, trazodone sits outside the DEA scheduling system entirely. That distinction makes it an appealing prescribing choice for clinicians treating patients who have addiction histories or who are in environments where controlled substances are harder to manage.4PubMed Central. Off-label policy through the lens of trazodone usage and spending in the United States
Why Some People Misuse It Anyway
The fact that trazodone doesn’t produce a classic high doesn’t mean nobody misuses it. Diversion data from the United States shows that trazodone, along with quetiapine and cyclobenzaprine, has seen a steady and significant increase in diversion from 2002 to 2017. By 2017, the rate was still far below opioid diversion, but it had grown more than fivefold compared to 2002. And while opioid diversion has decreased in recent years, trazodone diversion has continued to climb.5PubMed. The diversion of nonscheduled psychoactive prescription medications in the United States, 2002 to 2017
So why would anyone divert a drug that doesn’t get them high in the traditional sense? A few reasons. Some people in correctional facilities or residential treatment programs use trazodone (and quetiapine, which has a similar profile) as a sedative when preferred drugs aren’t available. Others crush and snort antidepressants including trazodone to try to intensify or speed up the effects. That practice carries its own risks, including seizures, confusion, and psychotic symptoms, and there is no good evidence that snorting trazodone produces euphoria.6PubMed Central. Abuse and misuse of antidepressants
In other words, trazodone misuse tends to be driven by availability and desperation rather than by any desirable subjective effect the drug reliably produces.
The mCPP Problem
There is one wrinkle in trazodone’s pharmacology that connects it to the recreational drug world, and it’s genuinely strange. When your body metabolizes trazodone, the liver enzyme CYP3A4 breaks it down into a compound called meta-chlorophenylpiperazine, or mCPP. This metabolite acts on serotonin receptors in ways that are quite different from trazodone itself. mCPP has non-selective serotonin agonist properties, meaning it activates serotonin receptors rather than blocking them. It influences mood, body temperature, and hormone release.7PubMed. Metabolism of m-CPP, trazodone, nefazodone, and etoperidone: clinical and forensic aspects
Here’s the strange part: mCPP, as a standalone compound, has been sold as a recreational drug around the world. It gained popularity partly because its effects loosely resemble MDMA, and it was initially misidentified as an ecstasy substitute, which allowed it to circulate widely before legal restrictions caught up. Multiple countries have since banned or restricted it. The fact that trazodone produces mCPP as a metabolite does not mean that taking trazodone feels like taking MDMA. The amount of mCPP generated from a normal trazodone dose is far lower than what recreational users of pure mCPP consume, and it’s produced gradually rather than hitting the brain all at once. But this metabolic pathway does help explain some of trazodone’s rarer and more puzzling side effects, particularly hallucinations and delirium in susceptible individuals.
Hallucinations and Delirium at Normal Doses
Most people who take trazodone experience nothing stranger than heavy drowsiness and maybe a dry mouth. But a small number of case reports describe vivid, distressing hallucinations appearing within days of starting the drug, even at standard doses. In one case, a 60-year-old man prescribed trazodone for insomnia showed up at the emergency department two days later experiencing visual hallucinations severe enough to require inpatient treatment. Stopping trazodone resolved the hallucinations completely.8PubMed Central. Distressing Visual Hallucinations after Treatment with Trazodone
In another case, a woman restarted trazodone at 100 mg and within five days developed incoherent speech, aggression toward children, and elaborate visual and auditory hallucinations. She described seeing fires and smoke, and spoke to people who were not present, calling children by name and telling them to have a snack.9Revista Colombiana de PsiquiatrÃa. Trazodone-induced delirium: case report
These are rare events, not typical ones. Researchers who reviewed multiple cases of trazodone-induced delirium noticed that the affected patients often had pre-existing brain lesions or thyroid problems, suggesting that underlying vulnerabilities play a role. One hypothesis is that mCPP, the serotonin-active metabolite, triggers these episodes in people whose brains are already sensitized.10PubMed. Occurrence of trazodone-induced delirium
For someone wondering whether trazodone might give them an interesting psychedelic-like experience, these cases are not that. The hallucinations described in the literature are frightening and disorienting, not enjoyable. They look more like delirium than like a trip.
The Side Effects That Are Common
While hallucinations grab attention because they’re dramatic, the everyday side effects of trazodone are more relevant to most people. Sedation is the big one and, at low doses, the intended one. But even when sedation is the goal, it can be more intense than expected: a meta-analysis of 44 randomized trials with nearly 4,000 participants found that trazodone did improve sleep quality and reduce nighttime awakenings, but it also led to significantly more adverse effects overall and more dropouts due to side effects compared to placebo.11PubMed. Effects of Trazodone on Sleep: A Systematic Review and Meta-analysis
Orthostatic hypotension, the blood pressure drop that happens when you stand up, is another effect that’s underappreciated. A study of older adults with hypertension found that trazodone users had substantially larger drops in blood pressure upon standing compared to non-users. The incidence of syncope (fainting) and falls was 25% overall, but among trazodone users it reached about 58%, compared to roughly 21% among those not taking the drug.12PubMed Central. Trazodone and Risk of Orthostatic Hypotension, Syncope and Falls in Geriatric Outpatients with Hypertension This is particularly dangerous for older adults, but it affects younger people too, especially if they stand up quickly after lying down, which is exactly what someone does after taking a sleep aid and getting up to use the bathroom at night.
Then there’s priapism, a prolonged and painful erection that constitutes a urological emergency. Trazodone’s alpha-adrenergic blocking properties interfere with the normal mechanism that allows an erection to subside. Research has shown that trazodone, at concentrations comparable to therapeutic blood levels, significantly impairs the smooth muscle contractions that control penile detumescence.13PubMed. Pathophysiology of prolonged penile erection associated with trazodone use Priapism is rare, but it’s one of the more memorable warnings attached to trazodone, and it can require surgical intervention if untreated.
Mixing Trazodone with Alcohol or Other Drugs
Because trazodone already produces profound sedation on its own, combining it with other depressants is a bad idea that people nonetheless try regularly. A study examining trazodone and alcohol together found that trazodone alone caused “profound depressant effects” on cognitive measures including reaction time, manual dexterity, and subjective drowsiness. Adding alcohol further impaired manual dexterity beyond what either substance caused alone. The researchers were explicit that their findings did not suggest it is safe for patients taking antidepressants to consume alcohol.14PubMed Central. An evaluation of possible interactions between ethanol and trazodone or amitriptyline
Combining trazodone with other serotonergic drugs carries a different danger: serotonin syndrome. This potentially life-threatening condition involves agitation, rapid heart rate, high blood pressure, tremor, and in severe cases, muscle rigidity and dangerously high body temperature. A case report documented serotonin syndrome in a 25-year-old man whose trazodone was titrated up rapidly alongside sertraline and risperidone.15PubMed. Take It Easy! Serotonin Syndrome Precipitated by the Rapid Titration of Sertraline and Trazodone in the Setting of Risperidone Use The risk increases when multiple serotonin-affecting medications are used together, which is relevant for anyone thinking about taking extra trazodone on top of an existing antidepressant regimen.
What Happens in Overdose
Trazodone is generally considered safer in overdose than older tricyclic antidepressants, but “safer” does not mean safe. Fatal overdoses from trazodone alone, while uncommon, have been documented. One case involved a 40-year-old patient who developed life-threatening heart rhythm abnormalities, including a type of irregular heartbeat called torsades de pointes and complete heart block. The patient progressed to multiple organ failure and died within 24 hours of admission.16PubMed. Fatal overdose with trazodone: case report and literature review
Another fatal case involved a 37-year-old woman who ingested about 6.5 grams of trazodone. She developed dangerously low sodium levels, had a seizure, and died from brain swelling. This case was the first reported death from a neurological complication of trazodone overdose specifically, highlighting that the drug’s overdose risks aren’t limited to the heart.17Clinical Neuropharmacology. Fatal Cerebral Edema, Seizures, and Hyponatremia After Trazodone Overdose
These are extreme scenarios involving massive doses, not what happens when someone accidentally takes an extra pill. But they illustrate why treating trazodone as a harmless or low-stakes drug to experiment with is a mistake.
Why Trazodone Gets Prescribed So Much for Sleep
Given all of the above, you might wonder why trazodone is everywhere. The answer has a lot to do with its unscheduled status and the limited options for treating chronic insomnia. Most effective sleep medications are controlled substances, meaning they come with prescribing restrictions, monitoring requirements, and the concern that patients could become dependent. Trazodone sidesteps all of that. Clinicians can prescribe it without the regulatory burden, and patients can fill it without the stigma or logistical hassle of a controlled prescription.
A meta-analysis of randomized placebo-controlled trials found that trazodone was effective for sleep maintenance, meaning people woke up less during the night, and it improved perceived sleep quality. It did not, however, improve sleep efficiency or several objective measures of how well people slept.18Sleep Medicine. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials In practical terms, people who take trazodone for sleep feel like they slept better even though some measurable aspects of their sleep don’t change much. That subjective improvement, combined with short-term tolerability, is enough to keep it in extremely heavy use as a sleep aid. Research has also shown its usefulness in specific populations, including patients with myasthenia gravis, where other sedatives might be risky.19PubMed Central. Efficacy and safety of low-dose trazodone hydrochloride for insomnia in patients with myasthenia gravis
The irony is that the very properties that make trazodone a poor recreational drug make it a popular clinical tool. It’s sedating without being euphoric, broadly effective without being addictive, and available without scheduling restrictions. For people searching for whether it can get them high, the honest answer is that trying will likely leave them feeling groggy, dizzy, and possibly nauseous, not pleasurably altered, and that the risks of taking more than prescribed extend well beyond an unpleasant experience.